Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024


Posted December 7, 2016 by Fiona-QYR

Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines

 
MRRS adds "Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024" latest studies, published in November 2016. It is a professional and in-depth study.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
2.3 Upcoming Related Reports 12
3 Disease Overview 13
3.1 Overview 13
3.2 Etiology and Pathophysiology 14
3.2.1 Etiology 14
3.2.2 Pathophysiology 21
3.3 Symptoms 23
3.4 Prognosis 24
3.4.1 Phases of Chronic HBV Infection 25
3.4.2 Complications of Chronic Hepatitis B 29
3.5 Quality of Life 31
4 Disease Management 33
4.1 Diagnosis and Treatment Overview 33
4.1.1 Diagnosis 33
4.1.2 Treatment Guidelines and Leading Prescribed Drugs 34
4.1.3 Clinical Practice 36
4.2 China 41
4.2.1 Screening and Diagnosis 41
4.2.2 Clinical Practice 43
5 Competitive Assessment 47
5.1 Overview 47
5.2 Product Profiles - Major Brands 51
5.2.1 Baraclude (entecavir) 51
5.2.2 Viread (tenofovir disoproxil fumarate) 56
5.2.3 Pegasys (peginterferon alfa-2a) 64
5.2.4 Hepsera (adefovir dipivoxil) 70
5.2.5 Tyzeka (telbivudine) 74
5.3 Other Therapeutics 80
5.3.1 Conventional and Pegylated Interferon alfa 80
5.3.2 Nucleos(t)ide Analogs 81
6 Unmet Need and Opportunity 83
6.1 Overview 83
6.2 Improvements in Long-Term Clinical Outcomes 86
6.2.1 Unmet Need 86
6.2.2 Gap Analysis 89
6.2.3 Opportunity 93
...

Browse Complete Report with TOC @
[URL]http://www.marketresearchreportstore.com/shop/hepatitis-b-virus-hbv-therapeutics-china-drug-forecast-and-market-analysis-to-2024[/URL]

List of Tables and Figures

1.1 List of Tables
Table 1: Modes of HBV Transmission 20
Table 2: HBV Serological Markers and Test Interpretations 23
Table 3: Symptoms of HBV Infection 24
Table 4: Phases of Chronic Hepatitis B Infection 26
Table 5: Key Complications of Chronic HBV infection 29
Table 6: Treatment Guidelines for Chronic Hepatitis B 35
...

Any questions, please feel free to contact us:

Tel: +00-1-626-3463946 - U.S

Email: [email protected]

[URL]http://www.marketresearchreportstore.com/[/URL]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country China
Categories Business
Last Updated December 7, 2016